KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Land & Improvements: 2010-2013

Historic Land & Improvements for Biomarin Pharmaceutical (BMRN) over the last 4 years, with Dec 2013 value amounting to $74.9 million.

  • Biomarin Pharmaceutical's Land & Improvements rose 33.81% to $74.9 million in Q4 2013 from the same period last year, while for Dec 2013 it was $74.9 million, marking a year-over-year increase of 33.81%. This contributed to the annual value of $74.9 million for FY2013, which is 33.81% up from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Land & Improvements of $74.9 million as of FY2013, which was up 33.81% from $56.0 million recorded in FY2012.
  • Biomarin Pharmaceutical's 5-year Land & Improvements high stood at $74.9 million for FY2013, and its period low was $37.7 million during FY2010.
  • In the last 3 years, Biomarin Pharmaceutical's Land & Improvements had a median value of $56.0 million in 2012 and averaged $59.8 million.
  • Data for Biomarin Pharmaceutical's Land & Improvements shows a peak YoY surged of 33.81% (in 2013) over the last 5 years.
  • Biomarin Pharmaceutical's Land & Improvements (Yearly) stood at $37.7 million in 2010, then grew by 28.99% to $48.6 million in 2011, then increased by 15.33% to $56.0 million in 2012, then skyrocketed by 33.81% to $74.9 million in 2013.